The Market Reports

Synopsis
The global market for Cell Bioreactors and Fermenters was estimated to be worth US$ 1669 million in 2024 and is forecast to a readjusted size of US$ 2771 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Cell Bioreactors and fermenters simulate a natural biochemical environment for the optimum growth of cells or tissues in microbial and cell culture. In Europe “fermentor” and “bioreactor” are synonyms. In the US however, the term “fermentor” is dedicated for microbial systems and “bioreactor” is used for animal cell cultivation systems. Bioreactors and fermenters can be separated into different types based on their material of construction, mechanism of mixing, working volume and overall purpose. The most prominent disctintion is usually made between single-use and multi-use equipment. While for single-use bioreactors the disposable culture vessel is made out of a plastic material, multi-use vessels are made from glass or stainless steel and require cleaning and sterilization between process runs. A very common mechanism of mixing is via a central stirring element in the culture vessel. This stirred-tank design has long been the gold standard for stainless steel bioreactors and is still followed for most single-use bioreactor systems. However, wave-mixing, or rocking motion technology can be a good alternative for shear stress sensitive cell lines. Here, mixing of gasses and nutrients is achieved through a rocking motion of the bioreactor. As bioreactors can have working volumes as small as a few milliliter to up to several thousand liter, it is often differentiated between lab-scale, pilot scale and manufacturing scale bioreactor systems. A special subset of lab-scale bioreactors are multiparallel systems that allow multiple culture experiments to be run at the same time. Finally, a distinction of bioreactor types is often made between mammalian cell culture and microbial culture bioreactors. Both cell types have very different requirements to their culture conditions, which is reflected in the design and configuration of specialized bioreactor systems.
Increasing Demand for Biologics: The demand for biologics such as monoclonal antibodies, vaccines, and gene therapies is rising. Bioreactors and fermenters are essential for culturing cells and microorganisms to produce these biologics. For example, the production of COVID - 19 vaccines have significantly increased the demand for related equipment. Development of Personalized Medicine: The development of personalized medicine requires the use of bioreactors and fermenters to produce customized biological drugs. The growing demand for personalized medicine has led to an increase in bioproduction, which in turn drives the growth of the bioreactor and fermenter market. Popularity of Single - Use Systems: Single - use bioreactors offer advantages such as reduced cross - contamination risk, lower cleaning and validation costs, and greater flexibility. They are easy to set up for continuous processing, and do not require the same utility and piping infrastructure as traditional stainless - steel bioreactors, which is why they are increasingly favored by biopharmaceutical companies. Technological advancements: The development of automation and intelligent control systems for bioreactors and fermenters has improved process repeatability, reliability, and production efficiency. These systems use sensors to monitor parameters such as temperature, pH, and dissolved oxygen, and transmit the data to control software for real - time adjustment.
This report aims to provide a comprehensive presentation of the global market for Cell Bioreactors and Fermenters, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cell Bioreactors and Fermenters by region & country, by Type, and by Application.
The Cell Bioreactors and Fermenters market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Bioreactors and Fermenters.
Market Segmentation
By Company
Thermo Fisher Scientific
Cytiva (Danaher)
Merck Millipore
Sartorius
Eppendorf
Getinge AB
T&J Bio-engineering
Infors AG
Bangalore Biotech Labs
Jiangsu KeHai Biological
H.E.L
Solida Biotech
SYSTAG
Solaris Biotechnology
Cleaver Scientific
HiTec Zang GmbH
2mag AG
Segment by Type
Single-use Equipment
Multi-use Equipment
Segment by Application
Biopharmaceuticals
Research and Development
Food and Beverage
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell Bioreactors and Fermenters manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cell Bioreactors and Fermenters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cell Bioreactors and Fermenters in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index